secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2022-11-16T23:59:59+00:00
Accession:  0001493152-22-032591
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio effects 1-for-50 reverse stock split to meet Nasdaq minimum bid price
--------------------------------------------------------------------------------

- Reverse split effective 5:00 p.m. ET Nov 15, 2022; common stock trades on split-adjusted basis from Nov 16 under same ticker PALI.
- Outstanding shares reduced from ~77.08M to ~1.54M; authorized shares decreased from 300M to 280M.
- Split intended to raise per-share price above $1 to regain compliance with Nasdaq minimum bid-price listing requirement.
- No fractional shares issued; cash paid in lieu based on Nov 15 closing price.
- Conversion price of Series A Convertible Preferred Stock proportionately adjusted following the reverse split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315222032591/0001493152-22-032591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315222032591/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-032591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer